Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NICO - CA209-891: Neoadjuvant and adjuvant nivolumab in oral cavity cancer
2017-005015-13Phase 2Unknown
- Sponsor
- The Clatterbridge Cancer Centre NHS Foundation Trust
- Start
- Jul 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in Oral Mucosal Carcinoma, sponsored by The Clatterbridge Cancer Centre NHS Foundation Trust. Status: unknown.
02
Drugs
03
Conditions
Oral Mucosal Carcinoma
Beyond the preview
Go deeper on 2017-005015-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005015-13.